✦ LIBER ✦

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer

✍ Scribed by Huggett, M T; Jermyn, M; Gillams, A; Illing, R; Mosse, S; Novelli, M; Kent, E; Bown, S G; Hasan, T; Pogue, B W; Pereira, S P

Book ID: 121859276
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 758 KB
Volume: 110
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2014.95

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Photodynamic therapy for locally advance

Photodynamic therapy for locally advanced pancreatic cancer (vertpac study)- final clinical results

✍ Huggett, M.T.; Jermyn, M.; Gillams, A.; Mosse, S.; Kent, E.; Bown, S.G.; Hasan, 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 57 KB

Phase-II study on stereotactic radiother

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

✍ Morten Hoyer; Henrik Roed; Lisa Sengelov; Anders Traberg; Lars Ohlhuis; Jorgen P 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 147 KB

A phase I/II study of gemcitabine-concur

A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis

✍ Kazuki Terashima; Yusuke Demizu; Naoki Hashimoto; Dongcun Jin; Masayuki Mima; Os 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 705 KB

750 POSTER Concurrent chemoradiation the

750 POSTER Concurrent chemoradiation therapy with 24-hour infusional gemcitabine in locally advanced pancreatic cancer: a phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A phase II study of gastrimmune in advan

A phase II study of gastrimmune in advanced pancreatic cancer

✍ Brett, Bernard T.; Smith, Stephen C.; Bouvier, Catherine V.; Michaeli, Dov; Hoch 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Verteporfin-based photodynamic therapy o

Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines

✍ Jonathan P. Celli; Nicolas Solban; Alvin Liang; Stephen P. Pereira; Tayyaba Hasa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Background and Objective: Pancreatic cancer is notoriously difficult to treat and resistant to virtually all therapeutics including gemcitabine, the standard front line agent for palliative chemotherapy. Early clinical studies point to a potential role for photodynamic therapy (PDT) in the managemen